Part B Insider - 2003 Issue 35
DRUG REIMBURSEMENT: Medicare Cuts 50 Drugs, Raises 49
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare drug reimbursement update focused on January 2004 pricing changes under the single-drug price methodology. It is relevant to billing and coding professionals who track outpatient drug payment changes, especially for chemotherapy and other injectable drugs. The discussion covers broad reimbursement reductions and increases, identifies affected HCPCS drug codes, and notes the transition to a new pricing basis in the following year.
Why This Topic Matters
Drug reimbursement changes can directly affect payment, charge capture, and budgeting for practices and facilities that administer injectable and chemotherapy drugs. Readers need to know which HCPCS drug codes are involved and how the policy shift changes the reimbursement landscape.
What You Will Learn
- How Medicare drug reimbursement changed for January 2004
- Which categories of drugs were affected by the pricing update
- How the article frames the shift from one payment benchmark to another
- Why these changes matter for practices that administer injectable drugs
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Oncology reimbursement staff
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com